ORTEC expands German healthcare footprint with strategic acquisition of Klages & Partner
13.1.2026 09:00:00 CET | news aktuell GmbH | Press Release
Zoetermeer, Netherlands - 13 January 2026 - Acquisition adds over 200 healthcare customers and sector-specific workforce management expertise to ORTEC’s portfolio
ORTEC, a global leader in supply chain planning and workforce management software, today announced the strategic acquisition of Klages & Partner, a German developer of clinical staff management software for hospitals, clinics, and care facilities meeting the complex demands of modern healthcare. Klages & Partner serves over 200 healthcare customers, primarily in Germany.
This acquisition supports ORTEC’s Workforce Management strategic objective to strengthen its position in the German healthcare sector, building on decades of experience and established leadership in workforce scheduling for the Dutch healthcare market, as well as an existing customer base across Belgium, Finland, Germany, the United Kingdom, and Australia. It expands ORTEC’s German industry-specific expertise while maintaining focus on delivering clarity, reliability, and human-centric technology across its solutions portfolio.
“Klages & Partner shares our commitment, quite simply, to making work work better for people in complex operational environments,” said Georgios Sarigiannidis, CEO of ORTEC. “Together, we can offer healthcare organizations even more powerful, user-friendly tools to plan, manage, and optimize their workforce, ultimately improving care delivery and staff satisfaction.”
Founded in 1991, Klages & Partner develops and distributes software designed hand-in-hand with healthcare professionals to address the unique challenges of clinical staff planning. Their solutions simplify complex workforce scheduling while ensuring fairness, efficiency, and compliance, enabling hospital and care facility teams to focus on the work that matters most: patient care.
ORTEC and Klages & Partner have a shared commitment to customer value, practical innovation, and building solutions that genuinely support healthcare professionals. ORTEC brings long-standing experience in workforce scheduling for healthcare organizations, while Klages & Partner contributes deep local market knowledge and trusted relationships within the German care sector.
The transaction closed at the end of December 2025.
About Klages & Partner
Klages & Partner develops and distributes clinical staff management software in close collaboration with hospital professionals. Serving more than 200 customers, primarily in Germany, the company’s mission is to make workforce planning in healthcare effective, fair, and sustainable.
Contacts
Rebecca NobleVice President Corporate CommunicationsORTEC BV
Media Contact
Images
About ORTEC
For more than 40 years ORTEC builds software for planning supply chains and managing workforces. We help organizations figure out the best way to use their people and resources, even when things change. Using our trusted, AI-powered technology dissolves noise and friction so people can stay in the flow. Our goal is simple: let our software provide confidence, fairness, and reliability, so everyone can focus on the work that truly matters. ORTEC is backed by Battery Ventures. Discover more at ortec.com.
Subscribe to releases from news aktuell GmbH
Subscribe to all the latest releases from news aktuell GmbH by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from news aktuell GmbH
Compax MVNE continues to support Airalo’s eSIM platform2.3.2026 13:38:56 CET | Press Release
Vienna, March 2nd, 2026: Compax, a leading solution provider in the MVNO and telco space, will continue to support Airalo, the world’s first and largest eSIM platform.
Grünenthal takes full ownership of Grünenthal Meds, the joint venture established with Kyowa Kirin for its established medicines brands2.3.2026 10:07:51 CET | Press Release
Grünenthal acquired Kyowa Kirin International’s 49% stake in ‘Grünenthal Meds’, a joint venture formed in 2023 to market the established medicines portfolio from Kyowa Kirin International. Through this acquisition, Grünenthal assumes the sole responsibility of a portfolio comprising 12 brands across six therapeutic areas and >60 markets.
Valle Venia presents new song by LPS feat. Lara: Where will it take me27.2.2026 10:15:00 CET | Press Release
The song describes the challenge of trusting the flow, relying on oneself, following one's own values with confidence. In a time when everything seems to begin to dissolve, when disorientation prevails more than ever and when one is searching for something to hold on to, certainty can be found in uncertainty. Lara's authentic interpretation, with her multi-faceted voice, conveys confidence in finding a way for oneself and others. In the faceless, noisy crowd, where glances are not returned and touches are not felt, one is pulled away by an invisible hand. You are on your own, but somewhere there is a light and a hope that guides you when the fog lifts and you find yourself in the certainty of meeting someone who “can read my mind and my soul.” Invisibly connected, across time and space, this path is open.
Vyoma awarded ESA data procurement contract for space-based data on small space debris24.2.2026 10:57:08 CET | Press Release
Munich, February 24th, 2026 – Vyoma, a Munich-based company providing Space Domain Awareness (SDA) capabilities, has been selected as the winner of the ESA tender on ”Data Procurement for Space-Based Statistical Data on Small Space Debris Phase 1”, funded via ESA‘s Space Safety Programme (S2P).
Medi-Globe Launches mAI Companion® — the World’s First Real Time AI Assistant for Pancreatic EUS, Co Developed with IHU Strasbourg —Now MDR CE Marked and Available for Clinical Use in Europe24.2.2026 10:00:00 CET | Press Release
Rohrdorf (Achenmühle), Germany — February 24, 2026 — Medi-Globe today announced the launch of mAI Companion®, a real-time medical AI solution designed to assist physicians in detecting pancreatic lesions during endoscopic ultrasound (EUS) — addressing one of the deadliest and most difficult-to-detect cancers, where earlier identification can dramatically change patient outcomes.
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom